妇科内分泌失调患者临床治疗效果分析
2017-12-07陈玲思
陈玲思
[摘要] 目的 探讨妇科内分泌失调患者的临床治疗效果。 方法 随机从我院2015年7月~2016年7月期间门诊妇科内分泌失调患者中,抽取80例纳入本研究,80例患者按入院单双顺序号分对照组(西医治疗)40例与研究组(中西医治疗)40例,将两组患者治疗状况纳入到讨论中,确保所得结论的可靠性。 结果 研究组总治疗疗效92.50%高于对照组80.00%(P<0.05)。对比两组患者性激素指数(FSH、E2),治疗前差异无统计学意义(P>0.05);治疗后,研究组高于对照组(P<0.05)。 结论 临床治疗妇科内分泌失调疾病可建议将中西医结合,其疗效突出,和单一性西医进行对比,疗效更为明显,可进一步推广和普及。
[关键词] 内分泌失调;妇科;治疗;疗效
[中图分类号] R711.6 [文献标识码] B [文章编号] 1673-9701(2017)36-0055-03
[Abstract] Objective To analyze the clinical treatment effect of gynecological endocrine disorders patients. Methods 80 cases from the gynecological endocrine disorders patients in the outpatient of our hospital from July 2015 to July 2016 were randomLy selected. 80 patients were divided into control group(n=40) treated with Western medicine and study group(n=40) treated with Chinese and Western medicine, according to admission odd and even sequence order. The treatment of both groups of patients was included in the discussion to ensure the reliability of the conclusions obtained. Results The total effective rate of the study group was 92.50%, higher than 80.00% of the control group(P<0.05).The sex hormone indexes(FSH, E2) were compared between the two groups. pre-treatment data was no statistical significance in the difference. After treatment, the levels of indexes in the study group were higher than those of the control group(P<0.05). Conclusion The traditional Chinese and Western medicine can be combined with in the clinical treatment of gynecological endocrine disorders, and its curative effect is outstanding. Compared with the single western medicine, the combined treatment has more obvious curative effect and can be further popularized.
[Key words] Endocrine disorders; Gynecology; Treatment; Efficacy
按照目前临床经验和相关总结来看,妇科疾病中较为常见的一种则为内分泌失调[1],目前临床多使用西医方式进行治疗,但单从疗效上来看,其进步空间仍然较大,随着进一步深入性研究发现,给予中西医方式进行治疗,其疗效明显,为此,本研究分组讨论80例患者观察其疗效情况,现报道如下。
1 资料与方法
1.1 一般资料
按入院单双号和1∶1的比例分两组讨论80例内分泌失调患者。患者均表现为程度不同的容易急躁、脾气大、肥胖、乳房疾病、体毛增多等。所有患者均接受阴道分泌物、孕激素、阴道彩超等检查,确认子宫形态正常。对照组年龄24.3~37.5岁,平均(26.4±1.3)岁,平均病程时间(4.6±0.5)年。研究组年龄24.6~37.8岁,平均(26.8±1.4)岁,平均病程时间为(4.7±0.5)年。两组患者基本资料比较,差异无统计学意义(P>0.05),具有可比性。
1.2 方法
对照组单一接受西药进行治疗,给予克罗米芬药物,给药剂量为:50~100 mg/d,在月经开始后第5天开始服用,持续治疗5 d。月经第10~14天时,卵巢直径>18 mm,则给予绒毛膜促性腺激素,给药剂量为5000~10 000 U/日,给药方式为肌肉注射。……
